XBIT Xbiotech Inc.

Fundamentals / CIK 0001626878 / USD

Xbiotech Inc. reported $128.6M in total assets and a net loss of $43.59M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open XBIT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$664.6M$332.3M$0-$106.2MFY 2016 Net Income: -$52.76M2016FY 2017 Net Income: -$33.15M2017FY 2018 Revenue: $0FY 2018 Net Income: -$21.14M2018FY 2019 Revenue: $0FY 2019 Net Income: $668.6M2019FY 2020 Revenue: $44.00MFY 2020 Net Income: -$11.22M2020FY 2021 Revenue: $18.39MFY 2021 Net Income: -$17.41M2021FY 2022 Revenue: $4.01MFY 2022 Net Income: -$32.90M2022FY 2023 Revenue: $0FY 2023 Net Income: -$24.56M2023FY 2024 Net Income: -$38.53M2024FY 2025 Net Income: -$45.54M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- $0 $4.01M $18.39M $44.00M $0 $0 -- --
Cost of Revenue -- -- $0 $651K $5.82M $34.55M $0 $0 -- --
Gross Profit -- -- $0 $3.36M $12.57M $9.45M $0 $0 -- --
Research & Development $47.39M $37.76M $32.85M $31.54M $28.27M $9.53M $24.09M $15.72M $26.42M $42.49M
Total Operating Expenses -- $42.47M $37.51M $37.85M $37.66M $27.73M $31.23M $20.99M $34.06M $52.76M
Operating Income -$55.69M -$42.47M -$37.51M -$34.49M -$25.08M -$18.28M -$31.23M -$20.99M -$34.06M -$52.76M
EBITDA -$54.00M -$40.73M -$35.81M -$31.88M -$22.43M -$16.04M -$28.87M -$18.56M -$32.58M -$52.06M
Income Before Tax -$45.30M -$38.56M -$24.31M -$33.59M -$25.46M -$12.83M $718.5M -$21.14M -$33.15M -$52.76M
Income Tax Expense $235K -$32K $244K -$688K -$8.04M -$1.61M $49.82M $0 $0 $0
Net Income -$45.54M -$38.53M -$24.56M -$32.90M -$17.41M -$11.22M $668.6M -$21.14M -$33.15M -$52.76M
Basic EPS -$1.49 -$1.26 -$0.81 -$1.08 -$0.58 -$0.36 $17.17 -$0.59 -$0.95 -$1.63
Diluted EPS -$1.49 -$1.26 -$0.81 -$1.08 -$0.58 -$0.36 $14.44 -$0.59 -$0.95 -$1.63
Basic Shares Outstanding 30.5M 30.5M 30.4M 30.4M 30.0M 30.8M 38.9M 35.8M 34.9M 32.4M
Diluted Shares Outstanding 30.5M 30.5M 30.4M 30.4M 30.0M 30.8M 46.3M 35.8M 34.9M 32.4M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $4.66M $5.30M $5.21M $25.36M $5.08M $5.34M $11.62M $7.82M
Total Operating Expenses $5.32M $6.15M -- -- $6.05M $6.34M $13.55M $8.75M
Operating Income -$5.32M -$6.15M -$6.27M -$29.75M -$6.05M -$6.34M -$13.55M -$8.75M
EBITDA -$5.07M -$5.84M -$5.94M -$29.38M -$5.62M -$5.90M -$13.11M -$8.31M
Income Before Tax -$4.42M -$6.68M -$5.46M -$26.82M -$5.91M -$1.73M -$10.86M -$10.55M
Income Tax Expense $35K $46K $49K $76K $102K $28K $29K -$41K
Net Income -$4.46M -$6.73M -$5.50M -$26.89M -$6.01M -$1.76M -$10.88M -$10.51M
Basic EPS -$0.15 -$0.22 -$0.18 -- -$0.20 -$0.06 -$0.36 --
Basic Shares Outstanding 30.5M 30.5M 30.5M -- 30.5M 30.5M 30.5M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $125.6M $172.7M $200.0M $157.3M $237.0M $237.4M $714.6M $15.82M $31.77M $34.32M
Short-Term Investments -- -- $0 $60.17M $0 -- -- -- -- --
Cash & Short-Term Investments $125.6M $172.7M $200.0M $217.5M $237.0M $237.4M $714.6M $15.82M $31.77M $34.32M
Accounts Receivable, Net -- $700K $860K $1.22M $0 $4.11M $0 -- -- --
Total Current Assets $127.0M $174.6M $201.7M $219.8M $246.9M $325.9M $716.3M $17.02M $33.33M $36.93M
Property, Plant & Equipment, Net $23.13M $24.53M $24.90M $26.26M $28.31M $27.34M $25.17M $27.33M $29.64M $10.14M
Total Non-Current Assets $23.13M $24.53M $24.90M $26.26M $28.31M $27.87M $100.6M $27.33M $29.64M $30.12M
Total Assets $150.1M $199.1M $226.6M $246.1M $275.2M $353.7M $816.9M $44.34M $62.97M $67.05M
Accounts Payable $1.53M $2.22M $2.52M $2.41M $2.07M $2.49M $2.15M $1.65M $1.73M $4.43M
Deferred Revenue (Current) -- -- -- -- -- $0 $4.50M -- -- --
Total Current Liabilities $7.93M $15.11M $6.10M $4.07M $3.45M $3.98M $60.19M $2.94M $2.79M $7.96M
Total Non-Current Liabilities $1.80M $1.72M $1.67M $1.64M $2.34M $1.12M $1.06M $3.0K $18K $23K
Total Liabilities $9.73M $16.82M $7.77M $5.70M $5.79M $5.11M $61.25M $2.95M $2.81M $7.99M
Common Stock $276.7M $273.1M $271.2M $267.3M $262.3M $249.8M $324.8M $279.4M $277.5M $242.4M
Retained Earnings -$136.4M -$90.84M -$52.31M -$27.75M $5.15M $97.57M $430.9M -$237.7M -$216.6M -$183.4M
Accumulated Other Comp. Income -- -- $0 $826K $1.97M $1.27M -$106K -$255K -$768K $57K
Total Stockholders' Equity $140.3M $182.3M $218.8M $240.4M $269.4M $348.6M $755.6M $41.40M $60.16M $59.06M
Total Equity $140.3M $182.3M $218.8M $240.4M $269.4M $348.6M $755.6M $41.40M $60.16M $59.06M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $105.0M $109.5M $115.5M $125.6M $147.4M $152.9M $155.9M $172.7M
Cash & Short-Term Investments $105.0M $109.5M $115.5M $125.6M $147.4M $152.9M $155.9M $172.7M
Accounts Receivable, Net -- -- -- -- $450K $480K $480K $700K
Total Current Assets $106.4M $111.2M $117.0M $127.0M $149.0M $154.9M $157.7M $174.6M
Property, Plant & Equipment, Net $22.25M $22.49M $22.79M $23.13M $23.47M $23.79M $24.18M $24.53M
Total Non-Current Assets $22.25M $22.49M $22.79M $23.13M $23.47M $23.79M $24.18M $24.53M
Total Assets $128.6M $133.7M $139.8M $150.1M $172.4M $178.7M $181.9M $199.1M
Accounts Payable $581K $1.10M $857K $1.53M $1.04M $1.43M $1.10M $2.22M
Total Current Liabilities $2.69M $3.35M $3.00M $7.93M $3.56M $3.86M $5.41M $15.11M
Total Non-Current Liabilities $1.85M $1.84M $1.82M $1.80M $1.78M $1.76M $1.74M $1.72M
Total Liabilities $4.55M $5.19M $4.82M $9.73M $5.34M $5.62M $7.15M $16.82M
Common Stock $277.1M $277.1M $276.9M $276.7M $276.6M $276.5M $276.4M $273.1M
Retained Earnings -$153.1M -$148.6M -$141.9M -$136.4M -$109.5M -$103.5M -$101.7M -$90.84M
Total Stockholders' Equity $124.1M $128.5M $135.0M $140.3M $167.1M $173.1M $174.7M $182.3M
Total Equity $124.1M $128.5M $135.0M $140.3M $167.1M $173.1M $174.7M $182.3M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$45.54M -$38.53M -$24.56M -$32.90M -$17.41M -$11.22M $668.6M -$21.14M -$33.15M -$52.76M
Depreciation & Amortization $1.69M $1.75M $1.70M $2.61M $2.65M $2.24M $2.36M $2.43M $1.48M $698K
Stock-Based Compensation $3.62M $1.75M $3.26M $5.06M $4.46M $12.58M $3.36M $1.66M $1.75M $5.57M
Change in Receivables -- -- -- $0 $4.11M -$4.11M $0 $0 -- --
Change in Payables -$688K -$364K $91K $357K -$514K -$334K $496K -$78K -$2.70M -$981K
Operating Cash Flow -$39.92M -$30.96M -$18.73M -$14.82M $69.44M -$65.15M -$18.27M -$16.54M -$33.65M -$46.02M
Capital Expenditure -$289K -$1.30M -$362K -$585K -$3.52M -$3.73M -$204K -$122K -$1.41M -$4.75M
Free Cash Flow -$40.21M -$32.27M -$19.09M -$15.41M $65.92M -$68.88M -$18.47M -$16.66M -$35.05M -$50.76M
Investing Cash Flow -$289K -$1.30M $61.50M -$63.89M -$3.52M -$3.73M $674.8M -$122K -$1.41M -$13.91M
Common Stock Issued -- -- $4.8K -- $8.00M $10.30M $3.80M -- $703K $1.81M
Share Repurchases -- $0 -$14K $0 -- -- -- -- -- --
Dividends Paid -- -- -- $0 -$75.00M $0 $0 -- -- --
Financing Cash Flow -$10.25M $10.45M -$9.0K $0 -$67.01M -$409.7M $42.10M $201K $33.32M $2.94M
Net Change in Cash -$47.13M -$27.35M $42.72M -$79.68M -$383K -$477.2M $698.8M -$15.95M -$2.56M -$56.73M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$4.46M -$6.73M -$5.50M -$26.89M -$6.01M -$1.76M -$10.88M -$10.51M
Depreciation & Amortization $252K $302K $332K $378K $427K $439K $442K $439K
Stock-Based Compensation $64K $172K $172K $162K $24K $107K $3.33M $628K
Change in Payables -$522K $246K -$678K $492K -$385K $330K -$1.12M $653K
Operating Cash Flow -$4.52M -$4.51M -$8.97M -$22.95M -$4.26M -$5.99M -$6.72M -$6.54M
Capital Expenditure -$12K $0 $0 -$34K -$110K -$51K -$94K -$84K
Free Cash Flow -$4.53M -$4.51M -$8.97M -$22.99M -$4.37M -$6.04M -$6.81M -$6.62M
Investing Cash Flow -$17K -$4.0K $9.0K -$34K -$110K -$51K -$94K -$84K
Financing Cash Flow $0 $0 $0 $0 $0 $0 -$10.25M $283K
Net Change in Cash -$4.49M -$5.93M -$10.09M -$21.82M -$5.57M -$2.96M -$16.78M -$10.44M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- -- -- 83.8% 68.4% 21.5% -- -- -- --
Operating Margin -- -- -- -860.1% -136.4% -41.5% -- -- -- --
Net Profit Margin -- -- -- -820.4% -94.7% -25.5% -- -- -- --
Return on Equity (ROE) -32.4% -21.1% -11.2% -13.7% -6.5% -3.2% 88.5% -51.1% -55.1% -89.3%
Return on Assets (ROA) -30.3% -19.4% -10.8% -13.4% -6.3% -3.2% 81.9% -47.7% -52.6% -78.7%
Current Ratio 16.01x 11.56x 33.07x 54.07x 71.49x 81.80x 11.90x 5.78x 11.94x 4.64x
Quick Ratio 15.83x 11.48x 32.93x 53.79x 68.63x 60.61x 11.87x 5.37x 11.38x 4.31x
Revenue Growth (YoY) -- -- -100.0% -78.2% -58.2% -- -- -- -- --
Gross Profit Growth (YoY) -- -- -100.0% -73.3% +33.1% -- -- -- -- --
Net Income Growth (YoY) -- -- -- -- -- -101.7% -- -- -- --
EPS Growth (YoY) -- -- -- -- -- -102.1% -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -- -121.3% -- -- -- -- -- --
Free Cash Flow Growth (YoY) -- -- -- -123.4% -- -- -- -- -- --
5Y Net Income / Share Growth -- -107.4% -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -35.1% -35.1% -29.7% -32.4% -17.5% -16.3% -22.6% -21.1%
Return on Assets (ROA) -33.9% -33.8% -28.7% -30.3% -16.9% -15.8% -21.7% -19.4%
Current Ratio 39.51x 33.15x 39.03x 16.01x 41.78x 40.16x 29.15x 11.56x
Quick Ratio 39.02x 32.67x 38.50x 15.83x 41.46x 39.78x 28.91x 11.48x
Source: SEC EDGAR CompanyFacts (CIK 0001626878) · from December 31, 2013 Data through September 30, 2026 · synced Nov 20, 2026, 05:52 UTC · Open in terminal